"It provides certainty, and that's important for any business."Philips CEO Roy Jakob says the 15% tariff on EU goods entering the US allows European businesses to "plan on certainty" https://t.co/j2EWFKi9uG https://t.co/Vp3gB1cKoD ...

US-Australia Trade Relations - Australia views the easing of beef import restrictions as an act of goodwill, not necessarily a direct response to US President Trump's requests [2][3] - Australia has a trade deficit with the US and minimal tariffs on US imports, except for 1-2 products [3] - The Australian Prime Minister aims to maintain Australia's bio security regime without compromising to US demands [4][5] Tariffs and Trade Deal Prospects - Australia currently faces a 10% tariff on its goods exported to the US [6] - Australia seeks to maintain the 10% tariff, if not eliminate it altogether, but the chances of elimination are slim [7] - Broader concerns for Australia involve the knock-on effects of tariffs imposed by the US on its other trading partners [8] Strategies for Economic Resilience - Australia is focusing on its own productivity, domestic competitiveness, and international competitiveness to increase the resilience of its exports [9] - Australia is reaching out to like-minded trading partners in the European Union, South Korea, and Japan to reinforce existing trade rules [10] - The industry believes that countries working together would be preferable in countering President Trump's trade policies, rather than negotiating individual bilateral deals [11]

Market Trends - Gold price declined following a stronger dollar after a tariff deal between the US and the European Union [1] - Market focus shifts to the potential extension of a trade truce between the US and China [1]

>> Thanks for watching. Fast money starts right now. >> Hey I'm Cramer, welcome to Mad Money. Welcome to Cramerica other my friends I'm just trying to make you a little money.My job is not just to entertain you but to educate and to teach you. So call me at one 800 703 CNBC or tweet me JimCramer. We've now got two trade deal wins on our hands.Last week's deal with Japan and this weekend's deal with the European Union. Despite the market's muted response Dow slipping 64 points S&P inching up 0.02% Nasdaq adv ...

European capitals defended the trade deal struck with Donald Trump, which will see the European Union accept a 15% tariff on most of its exports to the US while reducing levies on some American products to zero: Here’s your Evening Briefing https://t.co/QmFieEXVWI ...

Market Domination anchor Josh Lipton breaks down the latest market news for July 28, 2025. United States and Chinese officials met in Stockholm, Sweden, to discuss an extension of a tariff pause. European automakers face 15% tariffs. We look at the impact of the US-EU tariff framework and what it means for European carmakers. For more Market Domination videos, please visit: https://finance.yahoo.com/videos/series/market-domination/ #youtube #stocks #investing About Yahoo Finance: Yahoo Finance provides free ...

back with us, Ashley Parker, Mark McKinnon, and Max Rose. And Ashley, on Sunday, President Trump called this the biggest deal ever, but many of the things that he complained about, like the digital taxes, tax tech regulation, and demands to increase US beef and poultry imports, they were not included. So, what exactly did the White House accomplish here.>> Right. And I would just also add some of the things that the Europeans are promising to do, such as invest in US energy and buy more weapons from the Uni ...

UnitedHealth Group Outlook - Street is trying to understand the next 6-18 months, with less focus on 2025 [2] - Expectation of reintroduced guidance from UnitedHealth with a new CEO [2] - Potential earnings range of $18-$20 for the balance of the year or fiscal year 2025 may be sufficient [3] - Previous expectations for UnitedHealth were closer to the high $20s, now trying to determine the trough earnings number [4] - Focus is on price discovery and investor multiple on future earnings (2026, 2027, etc) [4] Pharmaceutical Tariff Implications - Potential tariff angle on big pharma is being considered [1][5] - Street is bracing for a potential 15%-25% tariff rate across the board for large-cap pharma [7] - Sector-wide tariff has been rumored for 6-8 weeks with no concrete action [7] - Clarity on tariffs could lead to a rally in pharma stocks [8] - Uncertainty remains regarding the administration's actions and clarity on pharmaceutical policies [9] Pharmaceutical Industry Challenges - Focus on bringing pharmaceuticals back to America [6] - Potential impact of most favored nations status [9] - Losses of exclusivity are well-documented challenges [10]

Market Sentiment - Tariff uncertainty has subsided, contributing to market's climb near all-time highs [2] - Optimism in the markets is fueled by hopes of reaching deals and lower tariff levels than initially discussed [2] - Inflation appears to be trending in the right direction, although it has recently stagnated [2] Valuation and Earnings - S&P 500's PE ratio has surged past 23 [3] - Current earning seasons could set the path for the remainder of the year [3] Technical Indicators - Relative Strength Index (RSI) is used to assess whether a stock is overbought or oversold [1] - RSI has climbed above 70 several times recently, indicating overbought conditions [1]

Our next guest argues the markets have gotten too sanguin. For more, let's bring in Tom Hancock, portfolio manager at GMO. Uh Tom, great to have you with us.Why sanguin. Well, I think the market is, for example, on the tariff side, it's 15% tariff suddenly no big deal. This would have freaked people out back in March or you know, sort of deepse people have forgotten about and we see the risk trade back on whether it's AI names or crypto names.market hitting new highs every day last week and things aren't re ...